Tuberculosis, a respiratory disease predominantly affecting the lungs, has been persistently plaguing public health with its sneaky transmission through the air, primarily via coughs or sneezes. But the way these bacteria manage to survive airborne travel could hold the key to halting their spread. Researchers from MIT and other institutions have uncovered a suite of genes that seem to become essential for Mycobacterium tuberculosis's survival once airborne, as reported by MIT News. These findings are not just a curiosity but could pinpoint new targets for treatments that might simultaneously address infection and block transmission.
According to the research team, including lead authors postdoc Xiaoyi Hu and professor Lydia Bourouiba, some of these genes were initially deemed nonessential but now appear crucial for the bacteria during its ‘flight’ from host to host. This discovery is changing the game on how we understand and potentially fight the spread of tuberculosis. "There is a blind spot that we have toward airborne transmission, in terms of how a pathogen can survive these sudden changes as it circulates in the air," Bourouiba told MIT News. Taking a fresh approach from the bacterium's perspective, they elucidated the defense mechanisms that M. tuberculosis might employ to weather the harsh journey through the air.
The collaborative effort, which stretched from MIT to institutions like Weill Cornell Medicine and the University of Washington, was rigorous in its attempt to create conditions mimicking the airborne travel of tuberculosis. They focused on crafting a droplet medium that closely matched the chemical composition, size, and viscosity of what patients expel when coughing or sneezing. Interestingly, these realistic drops seemed to better protect the bacteria as they dried, hinting at the intricate strategies tuberculosis utilizes to endure in the open air.
Carl Nathan, chair of the Department of Microbiology and Immunology at Weill Cornell Medicine and co-senior author of the study, highlighted the importance of disrupting the transmission of tuberculosis, particularly before people are even diagnosed. "Most people who exhale tuberculosis do not yet have a diagnosis. So we have to interrupt its transmission. And how do you do that if you don’t know anything about the process itself? We have some ideas now," Nathan told MIT News. The researchers have already begun to design experimental platforms to allow them to study droplets more accurately in flight, stepping even closer to deducing how to dismantle tuberculosis's airborne defenses.
This research, backed by the NIH, NSF, and other organizations, shows promise for both treatment and prevention. By targeting newly discovered genes, future therapies could not only treat infected people but also prevent the bacteria from spreading. This could break the transmission chain of a long-lasting pandemic and bring us closer to eradicating a disease that kills many each year.
